RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

BIBLIOGRAFÍA
489. Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz
MC, Ferrero JA. Change from three times a week on-line
hemodiafiltration to short daily on-line hemodiafiltration.
Kidney Int. 64:305-13, 2003.
490. Galland R, Traeger J, Arkouche W, Cleaud C, Delawari E,
Fouque D. Short daily hemodialysis rapidly improves nutritional
status in hemodialysis patients. Kidney Int 60: 1555-
60, 2001.
491. Marcucci R, Zanazzi M, Bertoni E, Rosatti A, Fedi S. Lenti M
y cols. Vitamin supplementation reduces the progression of
atherosclerosis in hyperhomocysteinemic renal-transplant
recipients. Transplantation 75: 1551-5, 2003.
492. Abdelfatah A, Ducloux D, Toubin G, Motte G, Alber D,
Chalopin JM. Treatment of hyperhomocysteinemia with folic
acid reduces oxidative stress in renal transplant recipients.
Transplantation. 73:663-5, 2002.
493. EBPG Expert Group on Renal Transplantation. European best
practice guidelines for renal transplantation. Section IV:
Long-term management of the transplant recipient. IV.5.5.
Cardiovascular risks. Hyperhomocysteinaemia. Nephrol
Dial Transplant 17 (Supl 4):28-29, 2002.
494. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE,
y cols. Association between cholesterol level and mortality
in dialysis patients: role of inflammation and malnutrition.
JAMA. 291:451-9, 2004.
495. Ross R. Mechanisms of disease: atherosclerosis an inflammatory
disease. N Engl J Med 340: 115-26, 1999.
496. Ridker PM. Clinical application of C-reactive protein for cardiovascular
disease detection and prevention. Circulation
107: 363-9, 2003.
497. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein,
the metabolic síndrome and risk of incident cardiovascular
events: an 8-year follow-up of 14719 initially healthy american
women. Circulation 107: 391-7, 2003.
498. Koenig W. Update in C reactive protein as a risk marker in
cardiovascular disease. Kidney Int 84: S58-S61, 2003.
499. Stenvinkel P, Heimburger O, Paultre F, y cols. Strong associations
between malnutrition, inflammation and atherosclerosis
in chronic renal failure. Kidney Int 55: 1899-1911, 1999.
500. Boltom CH, Downs LG, Victory JGG, Dwight JF, Tomson
CRV, Mackness MI y cols. Endothelial dysfunction in chronic
renal failure: roles of lipoprotein oxidation and pro-inflammatory
cytokines. Nephrol Dial Transplant 16: 1189-97,
2001.
501. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM,
Norpoth M, y cols. C-reactive protein in patients with chronic
renal diseases. Renal Fail 23: 551-62, 2001.
502. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow
J, Ikizler TA y cols. Increased prevalence of oxidant stress
and inflammation in patients with moderate to severe chronic
kidney disease. Kidney Int 65: 1009-1016, 2004.
503. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy
RP, y cols. Elevations of inflammatory and procoagulant biomarkers
in elderly persons with renal insufficiency.
Circulation 107:87-92,2003.
504. Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE,
De Zeeuw D. C-reactive protein is associated with renal
function abnormalities in a non-diabetic population. Kidney
Int. 63:654-61, 2003.
505. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor
for maintenance hemodialysis patients. Kidney Int 54:
773-782, 1998.
506. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive
protein predicts all-cause and cardiovascular mortality in
hemodiálisis patients. Am J Kidney Dis 35: 469-76, 2000.
507. Yeun JY, Kaysen GA. Acute phase proteins and peritoneal
dialysate albumin loss are the main determinants of serum
albumin in peritoneal dialysis patients. Am J Kidney Dis 30:
923-7, 1997.
508. Herbelin A, Urena P, Nguyen AT, Zingraff J, Descamps-
Latscha B. Elevated circulating levels of interleukin-6 in
patients with chronic renal failure.Kidney Int. 39:954-60,
1991.
509. Stenvinkel P. Inflammation in end-stage renal failure:could it
be treated? Nephrol Dial Transplant 17(supl 8): S33-S38,
2002.
510. Busch M, Franke S, Muller A, Wolf M, Gerth J, Ott U, y cols.
Potential cardiovascular risk factors in chronic kidney disease:
AGEs, total homocysteine and metabolites and C-reactive
protein. Kidney Int 2004; 66: 338-47.
511. Kaysen GA, Eisenrich JP. Characteristics and effects of
inflammation in end-stage renal disease. Semin Dial 16:
438-46, 2003.
512. López-Gómez JM, Pérez Flores I, Jofré R, Carretero D,
Rodriguez Benitez P, Villaverde M, y cols. The presence of a
failed kidney transplant in patients returning to hemodialysis
is associated with a chronic inflammatory state and erythropoietic
resistance.J Am Soc Nephrol 2004 (en prensa)
513. Bergstrom J, Heimburger O, Lindholm B, Qureshi AR.
Elevated C-reactive protein is a strong predictor of increased
mortality and low serum albumin in hemodalysis patients. J
Am Soc Nephrol 6: 573Abstract, 1995.
514. Kimmel PL, Philips TM, Simmens SJ, Peterson RA, Weihs KL,
Alleyne S y cols. Immunologic function and survival in
hemodialysis patients. Kidney Int 54: 236-244, 1998.
515. Noh H, Lee SW, Kang SW, Shin SK, Choi KH, Lee HY, Han
DS. Serum C-reactive protein: a predictor of mortality in
continuous ambulatory peritoneal dialysis patients. Perit
Dial Int. 18:387-94, 1998.
516. Iseki K, Tozawa M, Yoshi S, Fujiyama K. Serum C-reactive
protein (CRP) and risk of death in chronic dialysis patients.
Nephrol Dial Transplant 14: 1956-60, 1999.
517. Qureshi AR, Alvestrand A, Divino-Filho JC, y cols.
Inflammation, malnutrition and cardiac disease as predictor
of mortality in hemodialysis patients. J Am Soc Nephrol
13(supl 1): S28-36, 2002.
518. DeFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H,
Tcchi M y cols. Cardiac troponin and C-reactive protein for
predicting prognosis, coronary atherosclerosis, and cardiomyopathy
in patients undergoing long-term hemodialysis.
JAMA 290: 353-9, 2003.
519. Chauveau P, Level C, Lasseur C, Bonarek H, Peuchant E,
Montaudon D, y cols.C-reactive protein and procalcitonin as
markers of mortality in hemodialysis patients: a 2-year prospective
study. J Ren Nutr. 13:137-43, 2003.
520. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM.
Association of morbidity with markers of nutrition and
inflammation in chronic hemodialysis patients: a prospective
study. Kidney Int 55: 1945-51, 1999.
202